初次STEMI患者住院期间心梗后心衰发生率及1年预后
结果显示住院期间心衰发生率为41.8%,心衰组1年死亡率显著高于无心衰组。各心衰亚组中HFpEF死亡风险相对最低,LVEF值缺失者预后最差。
要点
- 初次STEMI住院期间心梗后心衰发生率为41.8%,需高度重视。
- 合并心梗后心衰的STEMI患者1年死亡率为23.3%,显著高于无心衰者。
- HFpEF预后相对较好,LVEF值缺失的心衰患者1年死亡风险最高。
核心结论
- 初次STEMI患者住院期间心梗后心衰的发生率为41.8%,1年死亡率达23.3%。
- 住院期间心梗后心衰是STEMI患者1年死亡的危险因素(HR=2.13,95%CI:1.70~2.67)。
- 心衰亚组间预后存在差异,HFpEF患者风险相对最低(HR=1.59,95%CI:1.16~2.17),LVEF值缺失者预后最差(HR=2.49,95%CI:1.91~3.26)。
研究设计与样本
- 数据来自河南STEMI注册登记研究,为多中心、前瞻性、观察性研究。
- 排除既往有心梗或心衰病史的患者,根据住院期间是否发生心衰分为心衰组和无心衰组。
- 心衰组依住院期间最后一次超声心动图LVEF分为HFrEF、HFmrEF、HFpEF及LVEF缺失组。
- 采用Kaplan-Meier生存分析及log-rank检验,多因素Cox脆弱模型分析1年死亡关联。
主要发现
- HFrEF、HFmrEF、HFpEF及LVEF缺失组的1年死亡率分别为29.6%(67/226)、20.8%(53/255)、11.7%(72/615)和34.1%(199/584)。
关键数值与推荐
- HFpEF定义为LVEF≥50%,HFmrEF为LVEF 41%~49%,HFrEF为LVEF≤40%。
- 心梗后心衰对1年死亡的HR=2.13,95%CI:1.70~2.67,以无心衰组为参照。
- HFpEF组1年死亡风险HR=1.59,95%CI:1.16~2.17。
- LVEF值缺失的心衰组1年死亡风险HR=2.49,95%CI:1.91~3.26。
临床怎么用
- 对初次STEMI患者应密切监测住院期间心衰的发生,及时识别高危人群。
- STEMI合并心衰患者1年死亡风险显著升高,需加强出院后随访与管理。
- LVEF值缺失的心衰患者预后最差,应尽量完善超声心动图评估并进行更积极的管理。
局限性
- 有694例(35.1%)心衰患者住院期间LVEF值缺失,可能影响亚组分析的完整性。
- 1年随访完成率为83.7%,存在一定比例的失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the incidence of in-hospital heart failure (HF) following myocardial infarction (MI) and 1-year mortality in patients with first ST-segment elevation myocardial infarction (STEMI), and to compare the 1-year mortality risk among different types of HF. Methods: Data were derived from the Henan STEMI registry, which was a multicentre, prospective, observational study in central China. After excluding patients with a history of MI or HF, patients with first STEMI were divided into the HF and non-HF groups according to the occurrence of in-hospital HF. Based on the left ventricular ejection fraction (LVEF) measured on the last echocardiogram during hospitalization, patients with HF were classified into HF with preserved ejection fraction (HFpEF, LVEF≥50%), HF with mildly reduced ejection fraction (HFmrEF, LVEF 41%-49%), HF with reduced ejection fraction (HFrEF, LVEF≤40%), and HF with missing LVEF. Survival analysis was performed using the Kaplan-Meier method, and differences between groups were assessed with the log-rank test. Multivariate Cox frailty models were used to analyze the associations of HF status (present vs. absent) and different LVEF subgroups with 1-year mortality, using the non-HF group as the reference. Results: A total of 4 737 patients with first STEMI were included in the final analysis, with a median age of 62.8 (52.4, 70.8) years, of whom 1 158 (24.4%) were female. During hospitalization, 1 978 cases (41.8%) developed HF following MI, including 268 (13.5%) with HFrEF, 309 (15.6%) with HFmrEF, 707 (35.7%) with HFpEF, and 694 (35.1%) with missing LVEF. A total of 3 967 (83.7%) patients completed the 1-year follow-up. The 1-year mortality was significantly higher among STEMI patients complicated by HF than in those without (23.3% (391/1 680) vs. 5.8% (132/2 287), log-rank P<0.001). Specifically, the rates were 29.6% (67/226) for HFrEF, 20.8% (53/255) for HFmrEF, 11.7% (72/615) for HFpEF and 34.1% (199/584) for HF with missing LVEF. Multivariate Cox frailty models identified in-hospital HF following MI as a risk factor for 1-year mortality (HR=2.13, 95%CI: 1.70-2.67). Notably, HFpEF was associated with the lowest risk of 1-year mortality (HR=1.59, 95%CI: 1.16-2.17), while the HF group with missing LVEF carried the highest risk (HR=2.49, 95%CI: 1.91-3.26). Conclusions: The incidence of HF following first STEMI during hospitalization was 41.8%, with a corresponding 1-year mortality of 23.3%. In-hospital HF following MI is a risk factor for 1-year mortality in patients with STEMI. Prognosis differed notably across HF subgroups: HFpEF was associated with the lowest risk, whereas patients with missing LVEF had the worst outcome. 目的: 探讨初次ST段抬高型心肌梗死(STEMI)患者住院期间心肌梗死(心梗)后心力衰竭(心衰)的发生率和1年死亡率,并比较不同类型心衰的1年死亡风险。 方法: 数据来自多中心前瞻性观察性研究——河南STEMI注册登记研究。排除该研究中既往有心梗或心衰病史的患者,依据住院期间是否发生心衰,分为心衰组和无心衰组。心衰组依据住院期间最后一次超声心动图测量的左心室射血分数(LVEF)分为射血分数保留的心衰(HFpEF,LVEF≥50%)、射血分数轻度降低的心衰(HFmrEF,LVEF 41%~49%)、射血分数降低的心衰(HFrEF,LVEF≤40%)及LVEF值缺失的心衰组。采用Kaplan-Meier法进行生存分析并进行log-rank检验。以无心衰组为参照,采用多因素Cox脆弱模型分析有无心衰及不同LVEF分组与1年内死亡率的关系。 结果: 最终纳入4 737例初次STEMI患者,年龄为62.8(52.4,70.8)岁,女性1 158例(24.4%)。住院期间发生心梗后心衰1 978例(41.8%),其中包括HFrEF患者268例(13.5%),HFmrEF患者309例(15.6%),HFpEF患者707例(35.7%)及LVEF值缺失的心衰患者694例(35.1%)。共有3 967例(83.7%)患者完成1年随访。心衰组STEMI患者的1年死亡率高于无心衰组[23.3%(391/1 680)比5.8%(132/2 287),log-rank P<0.001]。HFrEF、HFmrEF、HFpEF及LVEF值缺失的心衰组1年死亡率分别为29.6%(67/226)、20.8%(53/255)、11.7%(72/615)和34.1%(199/584)。多因素Cox脆弱模型分析显示,住院期间心梗后心衰是1年死亡的危险因素(HR=2.13,95%CI:1.70~2.67)。其中HFpEF组1年死亡风险最低(HR=1.59,95%CI:1.16~2.17),LVEF值缺失的心衰组1年死亡风险最高(HR=2.49,95%CI:1.91~3.26)。 结论: 初次STEMI患者住院期间心梗后心衰的发生率为41.8%,1年死亡率达23.3%。住院期间心梗后心衰是STEMI患者1年死亡的危险因素,且各心衰亚组间预后存在差异:HFpEF患者风险相对最低,LVEF值缺失者预后最差。.
引用
- Zhang, Wang, Yang, et al. [The incidence and 1-year prognosis of heart failure following myocardial infarction during hospitalization in patients with first STEMI]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42907221. doi:10.3760/cma.j.cn112148-20260514-00314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。